Updated 02:01 GMT, 16 Nov 2026 SPX 7,561.67 -0.40% NDX 27,943.74 -1.22% VIX 19.30 +3.21% GOLD 3,876.40 -0.25% CL 88.33 -0.26% BTC 64,613.34 +0.76%
NAS100 27,944 −1.22% S&P 7,562 −0.40% GOLD $3,876 −0.25% BTC $64,613 +0.76% VIX 19.30 +3.21% latest tape · as of 02:01 UTC
The Screen · Technology · Software - Application

AudioEye Inc

AEYE · NASDAQ · USD · Market cap $83M · 116 employees

AudioEye, Inc.

FAIL · Does not pass the screen
13.47 USD

Price as of 13 Nov 2026Daily close, not a live quote

Screened 2026-11-13 · the tape above runs as of 02:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price13.47 USD at the 13 Nov 2026 close
  • Our value readUndervalued vs our fair value, as of 13 Nov 2026
  • Our regime readMarkup, as of 15 Nov 2026
  • Ethical screenDoes not pass
  • OptionsOpen interest leans heavily to calls (put/call 0.13)
  • Last reviewed13 Nov 2026 (3 days ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: $11.71 to $19.52, base estimate $15.56 (screen dated 2026-11-13).

Current read
Markup ?
Undervalued · screened 2026-11-13
  • Trend Markup
  • Insiders insiders sold, $284,378, latest filing 2026-11-04
  • Positioning no disclosures inside 60 days, left as found
  • Options put/call open interest 0.13, read 2026-11-15
  • Ethical does not pass the values gate
Price13.47 USD
Fair value15.56
Ethical score70.0/100
Value readUndervaluedas of 13 Nov 2026
Our investment reviews on this name
2026-10-26Read Markup7.00+92.4% to today ✓Markdown gives way to Markup first Markup read since August
2026-10-02Read Markdown6.92+94.7% to today Accumulation gives way to Markdown first Markdown read since July
2026-09-21Read Accumulation6.61+103.8% to today ✓Markup gives way to Accumulation
2026-08-20Read Markup6.61+103.8% to today ✓Markdown gives way to Markup with volume flow in agreement

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its markup label.

AudioEye Inc holds its Markup at $13.47. Elevated stress, defensive posture warranted, held for 13 days.

As held on the ledger · 2026-11-13
PhaseMarkup
Quantitative stateElevated stress, defensive posture warranted, held for 13 days
Price at the screen$13.47
ValuationN/A trailing · 6.15 forward price to earnings
Values screenFAIL · score 70.0
Beta0.82
The Workings

Five Screens, Shown in Full

Does not pass. Debt ratio

TestFigureLimitWhat it meansStatus
Business activity Permissible Core business clean Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
Debt load 40.96% Below 33% Interest-bearing debt is 41.0% of its assets, above the one-third ceiling the screen allows. Fail
Interest-bearing cash 0.00% Below 33% Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. Pass
Receivables 36.75% Below 49% Money owed to the company is 36.8% of assets, under the 49% limit. Pass
Revenue purity 0.30% Below 5% Only 0.3% of revenue comes from non-compliant sources, under the 5% line. Pass

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Falls Short, in Plain English

AudioEye's business is in a permissible area, but its interest-bearing debt is about 41% of the company, well over the ~33% line, so it does not pass on the financial screens.

Read as at 2026-11-14. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when AEYE's ethical verdict changes

Today AEYE does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

Our analysis reads Undervalued vs our fair value, as of 13 Nov 2026: it trades at roughly a 13% discount to our $15.56 fair value, none competitive moat, 8.40% revenue growth.

How a fair value is estimated: discounted cash flow (DCF).

11.71Conservative15.56Base case19.52Growth case 13.47Price

Fair value range in USD, drawn from the 2026-11-13 screen. The gold marker is the market price at the same screen. A 13.4% discount to the base estimate.

The Street's Range
7.00Street low 15.50Street average 25.00Street high 13.47Price

Third-party analyst targets. The average target sits +15% from the screen price.

Reading the gap · Both our model and the analysts see meaningful upside from here.

Price History & Projections

Where our models see it going: fair-value estimate $15.56, with a range of $11.71 to $19.52, dated to the 2026-11-13 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words

Why it stands out

A 8%-growth business trading at just 6.2x forward earnings, with a none competitive moat. That is a 13% discount to our $15.56 fair value: the market is pricing it cautiously while the fundamentals argue otherwise.

The fundamentals · plain-English read
Forward P/E6.2xcheap for a company growing this fast
EPS, trailing-0.30
EPS, forward1.13
Revenue growth+8.4%steady growth
Profit margin-9.0%currently unprofitable
Return on equity-66.9%not currently earning a positive return on equity
FCF yield8.63%
Debt to equity5.33heavy leverage: higher risk if revenue softens
Current ratio1.03adequate liquidity, worth monitoring
Beta0.82steadier than the market
Short interest, float0.03%
52-week range5.31 - 16.39
MoatNONE
Market cap$83M
Employees116

Another profit measure, before interest, tax and non-cash costs: EBITDA.

The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it carries a real debt load, which raises the stakes if revenue slips.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

AEYE trades on NASDAQ. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-09 Markup $12.37 -5.1% Entry 13

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 5.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading overbought. Over the past year the shares are down 45%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (4 analysts) rates it none, with a mean price target of $16. Insiders have been net buyers over the past quarter.

2026-11-02 Markup $13.03 +86.1% Entry 12

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 86.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 45%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (4 analysts) rates it none, with a mean price target of $16. Insiders have been net buyers over the past quarter.

2026-10-26 Markup · changed $7.00 +0.0% Entry 11

The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 45%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (4 analysts) rates it none, with a mean price target of $16.

2026-10-19 Markdown $7.00 +1.0% Entry 10

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 1.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 45%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (4 analysts) rates it none, with a mean price target of $16.

2026-10-12 Markdown $6.93 +0.1% Entry 9

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 0.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 45%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (4 analysts) rates it none, with a mean price target of $16.

2026-10-02 Markdown · changed $6.92 +4.7% Entry 8

The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 4.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 45%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (4 analysts) rates it none, with a mean price target of $16.

2026-09-21 Accumulation · changed $6.61 +0.0% Entry 7

The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 45%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (4 analysts) rates it none, with a mean price target of $16.

2026-08-20 Markup · changed $6.61 +0.0% Entry 6

The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 45%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (4 analysts) rates it none, with a mean price target of $16.

2026-07-20 Markdown $6.61 -1.3% Entry 5

Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 1.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 45%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (4 analysts) rates it none, with a mean price target of $16.

2026-07-18 Markdown $6.70 +0.0% Entry 4

Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 45%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (4 analysts) rates it none, with a mean price target of $16.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Related Securities · Others in AEYE's Space

Screened names in the same industry · explore each on its own page.

The Insider Ledger · Form 4 Filings, As Filed
Most recent filings · AEYE
DateInsiderTitleTypeSharesValue
2026-11-04 Moradi David Exec COB, CPO, 10% S - Sale 22,359 $284,378
2026-10-30 Moradi David Exec COB, CPO, 10% S - Sale 177,641 $2,398,585
2026-10-30 Hawkins James B Dir P - Purchase 4,000 $52,600
2026-10-29 Hawkins James B Dir P - Purchase 3,000 $37,010

Public filings, recorded as found. The full tape lives at Insider Intelligence.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $7.69 -12.6% · $874 -12.6%
2 months $6.09 +10.3% · $1,103 +10.3%
3 months $5.52 +21.7% · $1,217 +21.7%
6 months $12.60 -46.7% · $533 -46.7%
1 year $12.28 -45.3% · $547 -45.3%
2 years $20.78 -67.7% · $323 -67.7%
3 years $5.86 +14.7% · $1,147 +14.7%
5 years $18.20 -63.1% · $369 -63.1%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever AEYE does next, these words stay.

AudioEye Inc · AEYE · Markup · $13.47
Recorded 2026-11-13 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.